Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study.

Gräfe V, Berger T, Hautzinger M, Hohagen F, Lutz W, Meyer B, Moritz S, Rose M, Schroder J, Spath C, Klein JP, et al. (2019)
Health economics review 9: 16.

Download
OA 1.03 MB
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Volltext vorhanden für diesen Nachweis
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Abstract / Bemerkung
BACKGROUND: Depression often remains undiagnosed or treated inadequately. Web-based interventions for depression may improve accessibility of treatment and reduce disease-related costs. This study aimed to examine the potential of the web-based cognitive behavioral intervention "deprexis" in reducing disease-related costs.; METHODS: Participants with mild to moderate depressive symptoms were recruited and randomized to either a 12-week web-based intervention (deprexis) in addition to care as usual (intervention group) or care as usual (control group). Outcome measures were health-related resource use, use of medication and incapacity to work as well as relating direct health care costs. Outcomes were assessed on patients' self-report at baseline, three months and six months.; RESULTS: A total of 1013 participants were randomized. In both groups total direct health care costs decreased during the study period, but changes from baseline did not significantly differ between study groups. Numeric differences between study groups existed in outpatient treatment costs. They could be attributed to differences in changes of costs for psychotherapeutic treatment from baseline. Whereas costs for psychotherapeutic treatment decreased in the intervention group, costs increased in the control group (-16.8% (80) vs. +14.7% (60)) (tdf=685=2.57; p=0.008).; CONCLUSION: The study indicates the health economic potential of innovative e-mental-health programs. There is evidence to suggest that the use of deprexis over a period of 12weeks leads to a decrease in outpatient treatment cost, especially in those related to different types of psychotherapeutic treatment.
Erscheinungsjahr
Zeitschriftentitel
Health economics review
Band
9
Art.-Nr.
16
eISSN
Finanzierungs-Informationen
Article Processing Charge funded by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.
PUB-ID

Zitieren

Gräfe V, Berger T, Hautzinger M, et al. Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. Health economics review. 2019;9: 16.
Gräfe, V., Berger, T., Hautzinger, M., Hohagen, F., Lutz, W., Meyer, B., Moritz, S., et al. (2019). Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. Health economics review, 9, 16. doi:10.1186/s13561-019-0233-y
Gräfe, V., Berger, T., Hautzinger, M., Hohagen, F., Lutz, W., Meyer, B., Moritz, S., Rose, M., Schroder, J., Spath, C., et al. (2019). Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. Health economics review 9:16.
Gräfe, V., et al., 2019. Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. Health economics review, 9: 16.
V. Gräfe, et al., “Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study.”, Health economics review, vol. 9, 2019, : 16.
Gräfe, V., Berger, T., Hautzinger, M., Hohagen, F., Lutz, W., Meyer, B., Moritz, S., Rose, M., Schroder, J., Spath, C., Klein, J.P., Greiner, W.: Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. Health economics review. 9, : 16 (2019).
Gräfe, Viola, Berger, Thomas, Hautzinger, Martin, Hohagen, Fritz, Lutz, Wolfgang, Meyer, Bjorn, Moritz, Steffen, Rose, Matthias, Schroder, Johanna, Spath, Christina, Klein, Jan Philipp, and Greiner, Wolfgang. “Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study.”. Health economics review 9 (2019): 16.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2019-06-26T12:39:29Z
MD5 Prüfsumme
be6519f82c14621516f1402aec2136cc

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 31175475
PubMed | Europe PMC

Suchen in

Google Scholar